| Ms Cheryl Anne Craig, MA, RN | |
|
45 West Upper Ferry Road, Ewing, NJ 08628-2717 | |
| (609) 882-5128 | |
| Not Available |
| Full Name | Ms Cheryl Anne Craig |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Psychiatric/mental Health, Adult |
| Location | 45 West Upper Ferry Road, Ewing, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770669756 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WP0809X | Registered Nurse - Psychiatric/mental Health, Adult | 26NR11650700 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Cheryl Anne Craig, MA, RN 45 West Upper Ferry Road, Ewing, NJ 08628-2717 Ph: (609) 882-5128 | Ms Cheryl Anne Craig, MA, RN 45 West Upper Ferry Road, Ewing, NJ 08628-2717 Ph: (609) 882-5128 |
News Archive
The second phase of a clinical trial testing a new stem-cell-based therapy on injured heart muscle has been launched by researchers at The University of Texas Medical School at Houston. It is the only study site in the Texas Medical Center.
A Norwegian study shows that two-year-olds with poor motor function also exhibit poor mathematical skills. This knowledge will make it easier for teachers to identify children who may need extra help.
Researchers at Wayne State University's Department of Nutrition and Food Science believe they've uncovered a unique method to control and regulate cholesterol using biologically active molecules isolated from ProAlgaZyme™ - a proprietary algal infusion produced by Health Enhancement Products, Inc., of Scottsdale, Arizona.
Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.
A newly-discovered hereditary mutation is responsible for an increased production of erythropoietin (EPO) in the blood.
› Verified 1 days ago
Ms. Patricia A Marino, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 865 Lower Ferry Rd, Apt 423, Ewing, NJ 08628 Phone: 609-323-7616 | |
Ms. Faniola Jean, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 240 Parkway Ave, Ewing, NJ 08618 Phone: 347-995-6976 | |
Vanessa Lee Piepszak, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 15 Wiscassett Ave, Ewing, NJ 08618 Phone: 609-731-4338 | |
Katrina Mcgowan, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Violet Ln, Ewing, NJ 08638 Phone: 732-995-0744 | |
Maria Riza Uy, MSN, APN, FNP-C Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Charles Ewing Blvd Ste 160, Ewing, NJ 08628 Phone: 800-370-3651 | |
Mrs. Jennifer Nolan, APN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 35 Esther Ave, Ewing, NJ 08618 Phone: 609-947-2844 |